top of page
News
Chat
Analysis
Education
About
Pricing
BPIQ API
BPIQ Blog
Mar 18, 2019
2 min read
FDA Accepts AIMT's Peanut Allergy Treatment BLA For Review
AIMT is seeking approval for AR101 as a treatment to reduce the risk of anaphylaxis following accidental exposure to peanuts in children...
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
